2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
Escalating doses and improving outcomes in cutaneous T-cell lymphomas
The importance of multiple myeloma foundations and a patient story
Paul Richardson et al.
Doublet vs triplet combination therapy for multiple myeloma
GVHD: helping patients cope with the side effects of transplantation